Our mission is opening a digital front door to a new kind of healthcare system, one that provides greater access to high quality, convenient and affordable care. No matter who a person is, where they come from, what they look like, or if they have insurance or not—Hims & Hers connects consumers with licensed medical professionals and enables everyone to seek health and wellness care.

HIMS

Andrew Dudum

Chief Executive Officer

Melissa Baird

Chief Operating Officer

Soleil Boughton

Chief Legal Officer and Corporate Secretary

Yemi Okupe

Chief Financial Officer

Chief Executive Officer And Board Of Director

Alex Bard

Board Of Director

Dr. Toby Cosgrove

M.D. Board Of Director

Kirsten Green

Jules Maltz

David Wells

Lynne Chou O’keefe

Andrea Perez

Ambar Bhattacharyya

Dr. Patrick Carroll

About HIMS

에 대한 최신 뉴스 Hims & Hers Health (NYSE:HIMS) 주식

Hims & Hers Health

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.

Hims & Hers Health, Inc. Class A Common Stock

NXPI

PLTR

TSLA

월요일(4일) 미국 증시는 S&amp;P 500 지수가 약 0.3% 하락하는 등 소폭의 하락세를 보였다. 다우존스 지수는 0.6% 하락한 41,794.60포인트를 기록했고, 나스닥 종합지수는 0.3% 하락한 18,179.98포인트를 기록했다.이날 미국 주식 시장에서 개인 트레이더와 투자자들이 가장 주목한 종목은 다음과 같다.

월요일 주목받은 주식: 팔란티어, 트럼프 미디어, 힘스 앤 허스, NXP 세미컨덕터 및 테슬라

Earnings

News

Guidance

Health Care

After-Hours Center

Movers

힘스 앤 허스 헬스(NYSE: HIMS)가 월요일 시장 마감 후 3분기 실적을 발표했다. 이 발표로 주가는 시간외 거래에서 7% 이상 상승했다. 보고서의 세부 사항은 다음과 같다.

힘스 앤 허스 헬스의 주식은 강력한 3분기 실적과 연간 전망 상향 발표로 7% 이상 상승

힘스 앤 허스 헬스(NYSE:HIMS)는 월요일 2분기 재무 결과를 발표했다. 보고서의 세부 정보는 다음과 같다. 주요 정보: 힘스 앤 허스 헬스는 분석가 합의 추정치인 3센트를 웃도는 주당 6센트의 분기 이익을 보고했다.

힘스 앤 허스는 예상보다 우수한 2분기 매출과 이익을 발표

Hims & Hers Health Inc

Wells Fargo analyst Yanan Zhu maintains Editas Medicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDIT#NASDAQ">EDIT</a>) with a Overweight and lowers the price target from $9 to $7.

Price Target

Analyst Ratings

EDIT

Wells Fargo Maintains Overweight on Editas Medicine, Lowers Price Target to $7

<a href="https://darkwebinformer.com/engineer-is-allegedly-selling-partner-portal-access-to-rapid7s-open-data/">https://darkwebinformer.com/engineer-is-allegedly-selling-partner-portal-access-to-rapid7s-open-data/</a>
&nbsp;
&#x1F517; DarkWebInformer.com - Cyber Threat Intelligence &#x1F4C5; Date: 2024-11-05 02:27:28 &#x1F6A8; Title: Alleged sale of partner portal access to Rapid7's Open Data &#x1F6E1;&#xFE0F; Victim Country: USA
&#x1F3ED; Victim Industry: Computer &amp; Network Security &#x1F3E2; Victim Organization: rapid7 &#x1F310; Victim Site: opendata.rapid7.com &#x1F4DC; Category: Data Breach &#x1F517; Claim: <a href="https://breachforums.st/Thread-PARTNER-PORTAL-ACCESS-TO-OPEN-DATA-RAPID7">https://breachforums.st/Thread-PARTNER-PORTAL-ACCESS-TO-OPEN-DATA-RAPID7</a> &#x1F575;&#xFE0F;&#x200D;&#x2642;&#xFE0F; Threat Actor: engineer &#x1F30D; Network: openweb &#x1F4DD; Description: The threat actor claims to be selling partner portal access to Rapid7's Open Data, which offers extensive data from Project Sonar's internet-wide surveys. Project Sonar collects global telemetry to identify common vulnerabilities, providing researchers with data to support public security projects. The alleged access includes 84.8 TB of data across 71,125 files, potentially enabling security insights for research, government security advocacy, and commercial security projects.

Rumors

Trading Ideas

Watching Rapid7; Traders Circulate Dark Web Informer Post Saying "Engineer Is Allegedly Selling Partner Portal Access To Rapid7's Open Data"

Wells Fargo analyst Elyse Greenspan maintains Everest Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EG#NYSE">EG</a>) with a Equal-Weight and lowers the price target from $406 to $402.

Wells Fargo Maintains Equal-Weight on Everest Group, Lowers Price Target to $402

Susquehanna analyst Biju Perincheril maintains AES (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AES#NYSE">AES</a>) with a Positive and lowers the price target from $24 to $21.

Susquehanna Maintains Positive on AES, Lowers Price Target to $21

Wells Fargo analyst Elyse Greenspan maintains Chubb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CB#NYSE">CB</a>) with a Equal-Weight and raises the price target from $266 to $268.

Wells Fargo Maintains Equal-Weight on Chubb, Raises Price Target to $268

Wells Fargo analyst Eric Luebchow maintains Public Storage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSA#NYSE">PSA</a>) with a Overweight and lowers the price target from $375 to $365.

Wells Fargo Maintains Overweight on Public Storage, Lowers Price Target to $365

ZCAR

Zoomcar Holdings Shares Resume Trade Then Again Halted On Circuit Breaker, This Time To The Downside, Stock Now Up 87.1%

Wells Fargo analyst Chris Carey maintains Monster Beverage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNST#NASDAQ">MNST</a>) with a Overweight and raises the price target from $57 to $60.

MNST

Wells Fargo Maintains Overweight on Monster Beverage, Raises Price Target to $60

SoundCloud, the artist-first platform that empowers artists and fans to connect and share through music, and PubMatic, an independent technology company delivering digital advertising's supply chain of the future, announce a new strategic partnership offering SoundCloud's premium advertising inventory across PubMatic's suite of tools and solutions. Combining SoundCloud's extensive reach and engaged user base with PubMatic's advanced advertising solutions, the partnership creates a powerful platform for advertisers to connect with audiences on a global scale.
For the first time, PubMatic will offer SoundCloud global programmatic inventory on all video and display advertising on desktop and mobile app. This integration will give advertisers unprecedented access to SoundCloud's vibrant community of music lovers, offering a unique opportunity to engage with audiences in a meaningful and immersive way. With 400+ million tracks from 40+ million artists across 193 countries, SoundCloud is the largest audio discovery platform in the world. Its global audience of tastemakers, trendsetters, and creators are redefining audio culture. PubMatic will provide expertise, unique monetization opportunities, and access to differentiated demand. The collaboration with SoundCloud aligns with PubMatic's mission to fuel the endless potential of internet content creators.

PUBM

SoundCloud And PubMatic Announce A New Strategic Partnership Offering SoundCloud's Premium Advertising Inventory Across PubMatic's Suite Of Tools And Solutions Creating A Powerful Platform For Advertisers To Connect With Audiences On A Global Scale

Looking into the current session, Air Products &amp; Chemicals Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APD#NYSE">APD</a>) shares are trading at $305.85, after a 0.08% drop. Over the past month, the stock decreased by 1.39%, but over the past year, it actually increased by 17.74%. With questionable short-term performance like this, and great long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2024/1730819874_0.png" alt="Past Year Chart" />

<h3>A Look at Air Products &amp; Chemicals P/E Relative to Its Competitors</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 51.67 in the Chemicals industry, Air Products &amp; Chemicals Inc. has a lower P/E ratio of 26.59. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1730819874_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

Markets

A Look Into Air Products & Chemicals Inc's Price Over Earnings

Wells Fargo analyst Michael Brown maintains Brookfield Asset Mgmt (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAM#NYSE">BAM</a>) with a Underweight and raises the price target from $48 to $51.

Wells Fargo Maintains Underweight on Brookfield Asset Mgmt, Raises Price Target to $51

Wells Fargo analyst Marc Torrente maintains Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) with a Overweight and raises the price target from $157 to $175.

FRPT

Wells Fargo Maintains Overweight on Freshpet, Raises Price Target to $175

Wells Fargo analyst Michael Brown maintains TPG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPG#NASDAQ">TPG</a>) with a Overweight and raises the price target from $67 to $68.

Wells Fargo Maintains Overweight on TPG, Raises Price Target to $68

Wells Fargo analyst Elyse Greenspan maintains Baldwin Insurance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BWIN#NASDAQ">BWIN</a>) with a Equal-Weight and lowers the price target from $46 to $43.

BWIN

Wells Fargo Maintains Equal-Weight on Baldwin Insurance, Lowers Price Target to $43

Zoomcar Holdings Shares Resume Trade Then Again Halt On Circuit Breaker To The Upside, Stock Now Up 98%

Wells Fargo analyst Daniel Politzer maintains Wynn Resorts (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WYNN#NASDAQ">WYNN</a>) with a Overweight and lowers the price target from $125 to $122.

WYNN

Wells Fargo Maintains Overweight on Wynn Resorts, Lowers Price Target to $122

Wells Fargo analyst Larry Biegelsen maintains Glaukos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GKOS#NYSE">GKOS</a>) with a Overweight and raises the price target from $135 to $145.

GKOS

Wells Fargo Maintains Overweight on Glaukos, Raises Price Target to $145

Wells Fargo analyst Steven Cahall maintains Fox (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOXA#NASDAQ">FOXA</a>) with a Overweight and raises the price target from $46 to $49.

FOXA

Wells Fargo Maintains Overweight on Fox, Raises Price Target to $49

Housing prices in key battleground states track much closer to conservative-leaning states than liberal ones, according to research from Realtor.com examining real estate trends since the 2020 election.
The analysis of seven swing states – Arizona, Georgia, Michigan, Nevada, North Carolina, Pennsylvania and Wisconsin – found median listing prices averaging $216 per square foot over the past year, well below the $322 average in blue states while hovering just above the $192 seen in red states.
Don't Miss:
<ul>
<li>This Jeff Bezos-backed startup will allow you to<a href="https://www.benzinga.com/money/bezos-landlord-100-dollars"> become a landlord in just 10 minutes, and you only need $100</a>.</li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a></li>
</ul>
&#8220;When it comes to home prices, swing states have mirrored red states much more than blue states over the past four years,&#8221; Realtor.com senior economist Ralph McLaughlin was quoted in the report. The data shows swing state prices running 30% to 40% below blue state levels but only 10% to 20% above red states.
Price growth in the much-contested states <a href="https://www.benzinga.com/real-estate/24/05/39112751/home-values-in-swing-states-may-swing-the-2024-presidential-vote">has followed a middle path since 2020</a>. From October 2020, swing state listing prices rose 35% on a square-foot basis, compared to 24% in red states and 40% in blue states. The median listing price in swing states is $399,000, between red states at $371,129 and blue states at $554,321.
Trending: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die." <a href="https://www.benzinga.com/money/connect-invest-real-estate-notes">These high-yield real estate notes that pay 7.5% &#8211; 9% make earning passive income easier than ever.</a>
Realtor noted that the price patterns align with broader demographic trends, as swing states typically occupy a middle ground in key metrics like urbanization, education levels and wages. A separate Realtor.com analysis from May found <a href="https://www.benzinga.com/real-estate/24/05/38949118/swing-state-housing-prices-could-sway-2024-election">housing affordability in swing states closely tracking the national average</a>.
Housing policy has become a campaign issue, with Vice President Kamala Harris proposing builder tax credits to create three million new homes and $25,000 in down-payment assistance for first-time buyers. Former President Donald Trump&#8217;s housing proposals center on immigration restrictions and deregulation. His platform includes preventing undocumented immigrants from accessing mortgages. <a href="https://www.benzinga.com/real-estate/24/10/41251977/trump-and-harris-reveal-their-game-plans-to-tackle-skyrocketing-housing-prices-heres-what-has-worked">According to previous Benzinga reporting</a>, the policy could have broader implications for construction costs, as immigrants make up about 20% of the construction workforce.
See Also: ‘Beating the market through ethical real estate investing' —<a href="https://www.benzinga.com/money/invest-with-roots"> this platform aims to give tenants equity in the homes they live in while scoring 17.38% average annual returns for investors – here&#8217;s how to join with just $100</a>
The former president&#8217;s plan also targets zoning regulations, which he identifies as a key barrier to new housing development. His proposed reforms would streamline environmental requirements and permit processes that he says currently impede builders and drive up costs.
According to McLaughlin, if the price growth seen in home prices since the last election matters to voters, "it implies that swing state voters may have federal housing policy on their minds much less than voters in blue states but perhaps a little more than voters in red states,&#8221; he said.
Read Next:
<ul>
<li>Invest in $20+ trillion home equity market today across cities like Austin, Miami, and Los Angeles through a <a href="https://www.benzinga.com/money/nada-cityfunds">unique 5-year term fund targeting a 14-20% IRR with minimums as low as $2,500</a></li>
<li>These five entrepreneurs are worth $223 billion –<a href="https://www.benzinga.com/money/arrived-homes-private-credit-fund"> they all believe in one platform that offers a 7-9% target yield with monthly dividends</a></li>
</ul>

Real Estate

'30% Less Than Blue': Swing State Home Prices Align With Red States, Says Realtor.com

Although the broad market has clocked impressive returns in 2024, with the benchmark S&amp;P 500 Index, tracked by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), returning more than 20%, legendary investor Warren Buffett has <a href="https://www.benzinga.com/markets/equities/24/10/41294370/warren-buffett-continues-trimming-bank-of-america-position-no-longer-needs-to-report-sales">been a cautious seller</a>.
The Berkshire Hathaway (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) chairman notably sold over $100 billion of Berkshire&#8217;s largest holding, Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), capitalizing on the tech giant's valuation and reducing exposure to preserve gains. Additionally, he offloaded substantial portions of Bank of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>), trimming Berkshire&#8217;s stake below the critical 10% ownership threshold.
While it is hard to speculate on Buffett's actions, his decision to sell a bank might be tied to an anticipation of lower interest rates. Berkshire still owns about 10% of the stock, but now it is not required to file Form 4 with the SEC within two business days—it can file Form 13F as far as 45 days into 2025.
In addition to a solid orientation around the Fed&#8217;s actions, Buffett's expertise in the insurance industry is noteworthy, as decades of ownership of GEICO give him a vantage point over the market.
Per <a href="https://x.com/KobeissiLetter/status/1852787764720476326">the </a>Kobeissi Letter, he now holds a record $288 billion of U.S. Treasury bills, which is $93 billion more than the Fed.
"Opportunities for investment that are open to the analyst who stresses quantitative factors have virtually disappeared…" Buffett <a href="https://www.ivey.uwo.ca/media/2975913/buffett-partnership-letters.pdf">wrote</a> in May 1969, clarifying the decision to close down his $100 million Buffett Partnership, Ltd. However, in 2024, he's at the helm of one of the largest publicly traded companies in the world.
Buffett's investment preferences are fairly well-known. He seeks companies with a high return on equity (ROE) that demonstrate efficient use of capital and consistent profit margins that indicate financial health.
Furthermore, he favors the "product moat," or competitive advantage, as it creates long-term stability and growth, fends off competition, and sustains profitability. However, a cornerstone of Buffett&#8217;s investing philosophy is his rigorous preference for buying assets at a discount to their intrinsic value.
This preference is so strong that he suspended Berkshire Hathaway's buybacks in the third quarter until the "price is below Berkshire's intrinsic value."
While there are still companies meeting Buffett's criteria, finding them at a bargain has become challenging – particularly at a size that would create a meaningful return for his $325 billion cash pile.
Berkshire Hathaway has returned 22.02% year-to-date.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/personal-finance/24/11/41726342/can-you-guess-what-asset-the-ultra-wealthy-invest-in-most-heres-a-hint-its-not-stocks">Can You Guess What Asset the Ultra-Wealthy Invest In Most? Here&#8217;s A Hint: It&#8217;s Not Stocks</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Equities

AAPL

Buffett Amasses A $325 Billion Cash Pile, Halts Berkshire Buybacks

Says trajectory in 2024 "nothing short of phenomenal." Says business trajectory setting "robust foundation" for 2025. Comments taken from Q3 earnin...

Hims & Hers to stop reporting on orders, average order value after 2024

Check out this evening's top movers from around Wall Street, compiled by The Fly.&nbsp;&nbsp; HIGHER AFTER EARNINGS – QuinStreet&nbsp;(QNST)&nbsp;u...

Closing Bell Movers: Palantir jumps 13% after results

Hims & Hers Health, Inc. (HIMS) Q3 2024 Earnings Call Transcript

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Hims & Hers Health (HIMS – Research Report), Avanos Medical (AVNS...

Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS), Avanos Medical (AVNS) and Alphatec Holdings (ATEC)

Hims & Hers: A Lot More Than Just GLP-1, And It's Proving Its Ability To Grow

Hims & Hers Health, Inc. ( ($HIMS) ) has released its Q3 earnings. Here is a breakdown of the information Hims & Hers Health, Inc. presented to its...

Hims & Hers Health Reports Strong Q3 2024 Growth

Biggest stock movers Tuesday: CLF, PLTR, and more

In a report released today, Korinne Wolfmeyer from Piper Sandler maintained a Hold rating on Hims & Hers Health (HIMS – Research Report), with a pr...

Piper Sandler Remains a Hold on Hims & Hers Health (HIMS)

Hims & Hers to launch a generic for Novo's older GLP-1

Seaport Global analyst Aaron Kessler maintained a Buy rating on Hims & Hers Health (HIMS – Research Report) today and set a price target of $32.00....

Seaport Global Sticks to Their Buy Rating for Hims & Hers Health (HIMS)

ALAB

ATEC

ATUS

AVNS

BOOM

BOWL

CRUS

DLTR

EVER

FANG

FWRD

HDSN

HOLX

ILMN

LSCC

NONOF

QNST

SLAB

VMEO

VRTX

Screenshot 2024-09-04 at 5.36.44 PM

Biotech

General

MGRX

Prescribing The Future: How MangoRx Is Shaking Up Telemedicine With A Fresh Platform

Screenshot 2024-07-09 at 1.59.17 PM

Erectile Function Vs Erectile Dysfunction: How MangoRx&#39;s (NASDAQ: MGRX) Product Sets Itself Apart And Caters To A Large Market (Pun Intended)

Emerging Telemedicine Leaders: Stocks Shaping Healthcare's Digital Future

Press Releases

Hims & Hers Health, Inc. Reports Second Quarter 2024 Financial Results

Hims & Hers to Offer Access to Compounded GLP-1 Injections for as Low as $99/Month to U.S. Military, Veterans, Teachers, Nurses and First Responders

Hims & Hers Health Set to Join S&P SmallCap 600

Hims & Hers to Announce Third Quarter 2024 Financial Results on November 4, 2024

Hims & Hers names Dr. Jessica Shepherd as Chief Medical Officer of Hers

Define Ventures Appoints Bruce Broussard as Venture Partner

How Compounded Treatments Are Helping Hims & Hers Customers Meet Their Weight Loss Goals

Hims & Hers Health, Inc. Reports Third Quarter 2024 Financial Results

GDRX

SPGI

TDOC

Addus HomeCare Corporation - Common Stock

Addus HomeCare

Agilon Health

Amedisys

AMN Healthcare Services

Astrana Health

BrightSpring Health Services, Inc. - Common Stock

BrightSpring Health

Chemed

Cigna

CorVel

CVS Health

Quest Diagnostics Incorporated Common Stock

Quest Diagnostics

DaVita

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)

Fresenius Medical Care

Guardant Health

LifeStance Health Group, Inc. - Common Stock

LifeStance Health Gr

Labcorp Holdings

Pediatrix Medical Group, Inc. Common Stock

Pediatrix Medical Group

NeoGenomics

Option Care Health

Premier

Pennant Gr

Privia Health Gr

R1 RCM

RadNet

GeneDx Holdings Corp. - Class A Common Stock

GeneDx Hldgs

Canaccord Genuity

B of A Securities

Needham

Deutsche Bank

Piper Sandler

WIIM

Hims & Hers Health shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY24 revenue guidance above estimates.

월요일(4일) 미국 증시는 S&amp;P 500 지수가 약 0.3% 하락하는 등 소폭의 하락세를 보였다. 다우존스 지수는 0.6% 하락한 41,794.60포인트를 기록했고, 나스닥 종합지수는 0.3% 하락한 18,179.98포인트를 기록했다.



이날 미국 주식 시장에서 개인 트레이더와 투자자들이 가장 주목한 종목은 다음과 같다:



<h2 class="wp-block-heading">팔란티어 테크놀로지스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>)</h2>



팔란티어 주가는 1.22% 하락한 41.41달러에 마감했으며 장중 최고가와 최저가는 각각 42.04달러, 41.03달러였다. 팔란티어는 <a href="https://kr.benzinga.com/news/usa/stocks/%ED%8C%94%EB%9E%80%ED%8B%B0%EC%96%B4%EC%9D%98-%EC%A3%BC%EC%8B%9D%EC%9D%80-%EA%B0%95%EB%A0%A5%ED%95%9C-3%EB%B6%84%EA%B8%B0-%EC%8B%A4%EC%A0%81%EA%B3%BC-%EC%97%B0%EA%B0%84-%EC%A0%84%EB%A7%9D-%EC%83%81/">3분기 매출</a>이 전년 동기 대비 30% 증가한 7억 2,552만 달러로 컨센서스 예상치인 7억 113만 달러를 상회했다고 발표했다. 미국 매출은 &#8216;끊임없는 AI 수요&#8217;에 힘입어 전년 대비 44% 증가한 4억 9,900만 달러를 기록했다.



<h2 class="wp-block-heading">트럼프 미디어 앤 테크놀로지 그룹&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>)</h2>



변동성이 컸던 트럼프 미디어의 주가는 12.37% 상승한 34.34달러로 마감했다. 트럼프 미디어는 미국 대선 결과를 대리하는 종목이었고, 대선 캠페인이 이 막바지에 이르면서 지난주 하락세를 보였다. 여러 경합주에서 카멀라 해리스가 사전 투표한 유권자들 사이에서 선두를 달리고 있다는 여론조사 결과가 나오는 등 <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41715442/trump-media-stock-volatile-on-election-eve-as-polls-betting-markets-predict-tight-white-ho">선거는 여전히 매우 치열한 접전</a> 양상을 보이고 있다.



관련 기사:&nbsp;<a href="https://kr.benzinga.com/news/usa/stocks/%ED%85%8C%EC%8A%AC%EB%9D%BC-%ED%88%AC%EC%9E%90%EC%9E%90%EB%93%A4-%EA%B0%80%EC%B9%98%EC%99%80-%EC%A3%BC%EA%B0%80%EB%A5%BC-%ED%98%BC%EB%8F%99-%EA%B2%8C%EB%A6%AC-%EB%B8%94%EB%9E%99%EC%9D%80/">테슬라 투자자들, ‘가치와 주가를 혼동', 게리 블랙은 주가 회복을 예상</a>



<h2 class="wp-block-heading">힘스 앤 허스 헬스&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>)</h2>



힘스 앤 헐스의 주가는 1.96% 상승한 20.76달러에 마감했다. 힘스 앤 헐스의 <a href="https://kr.benzinga.com/news/usa/stocks/%ED%9E%98%EC%8A%A4-%EC%95%A4-%ED%97%88%EC%8A%A4-%ED%97%AC%EC%8A%A4%EC%9D%98-%EC%A3%BC%EC%8B%9D%EC%9D%80-%EA%B0%95%EB%A0%A5%ED%95%9C-3%EB%B6%84%EA%B8%B0-%EC%8B%A4%EC%A0%81%EA%B3%BC-%EC%97%B0%EA%B0%84/">3분기 실적</a>은 주당순이익 32센트, 분기 매출 4억 160만 달러로 애널리스트 컨센서스 예상치를 상회했으며, 전년 동기 대비 증가했다.



<h2 class="wp-block-heading">NXP 세미컨덕터 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>)</h2>



NXP 세미컨덕터 주가는 0.71% 하락한 236.90달러에 마감했다. NXP 세미컨덕터의 3분기 주당순이익 3.45달러로 <a href="https://kr.benzinga.com/news/nxp-%ec%84%b8%eb%af%b8%ec%bb%a8%eb%8d%95%ed%84%b0-%ec%98%88%ec%83%81%eb%b3%b4%eb%8b%a4-%eb%82%98%ec%9d%80-1%eb%b6%84%ea%b8%b0-%ec%8b%a4%ec%a0%81-%eb%b0%9c%ed%91%9c%ec%97%90-%ec%a3%bc%ea%b0%80/">애널리스트 컨센서스 예상치를 상회</a>했다. 그러나 3분기 매출은 32억 5천만 달러로 컨센서스 추정치에 부합했으며, 전년 동기 대비 감소한 것으로 나타났다.



<h2 class="wp-block-heading">테슬라&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)</h2>



테슬라 주가는 2.47% 하락한 242.84달러로 마감했다. 테슬라는 이전에 셀러브리티 프로모션을 기피했지만, 한국의 김예지 권총 사격 선수를 브랜드 홍보 대사로 영입하면서 마케팅 전략의 <a href="https://www.benzinga.com/news/24/11/41726158/did-elon-musk-change-his-mind-on-celebrity-endorsements-tesla-signs-deal-with-viral-olympian-in-this">잠재적 변화</a>를 시사했다.



사진 제공: Shutterstock



더 읽기:



<ul>
<li><a href="https://www.benzinga.com/news/24/11/41705158/cathie-wood-says-trumps-ideas-on-eliminating-income-tax-and-imposing-tariffs-brings-back-vibes-of-ea?itm_source=parsely-api" target="_blank" rel="noreferrer noopener"><a href="https://www.benzinga.com/news/24/11/41705158/cathie-wood-says-trumps-ideas-on-eliminating-income-tax-and-imposing-tariffs-brings-back-vibes-of-ea?itm_source=parsely-api">캐시 우드, &#8220;소득세 철폐와 관세 부과 관련 트럼프의 아이디어가 미국 초창기 분위기 되살려&#8221;</a></a></li>
</ul>



이 기사는 <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>를 통해 생성되었으며 <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>이 편집했습니다.



Benzinga Pro의 독점 뉴스 및 도구로 수익률을 높여보세요. 독점 속보, 스캐너 등 Benzinga Pro의 강력한 도구를 활용해 다른 트레이더보다 앞서갈 수 있습니다. 14일 무료 체험을 시작하려면 <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하세요!

힘스 앤 허스 헬스(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>)가 월요일 시장 마감 후 3분기 실적을 발표했다. 이 발표로 주가는 시간외 거래에서 7% 이상 상승했다. <a href="https://www.benzinga.com/pressreleases/24/11/b41727141/hims-hers-health-inc-reports-third-quarter-2024-financial-results">보고서의 세부 사항</a>은 다음과 같다.
세부 사항: 힘스 앤 허스는 분기당 주당 순이익이 32센트로 분석가 컨센서스 추정치인 4센트를 초과했다고 발표했습니다. 분기 매출은 4억 1,600만 달러로, 분석가 컨센서스 추정치인 3억 8,220만 달러를 초과했으며, 작년 같은 기간의 2억 2,670만 달러에 비해 증가했다.
<ul>
<li>구독자는 분기 동안 200만 명에 달해 전년 대비 44% 증가했다.</li>
<li>3분기 총 이익률은 2024년 79%로 2023년 3분기 83%에 비해 감소했다.</li>
<li>2024년 3분기 순이익은 7,560만 달러로, 이는 세금 평가 충당금 해제에 따른 6,080만 달러의 세금 혜택이 포함된 것이며, 현재 기간 세금 비용으로 부분 상쇄되었다. 이는 2023년 3분기 순손실 760만 달러와 비교된다.</li>
</ul>
다음 읽어볼 기사: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41715442/trump-media-stock-volatile-on-election-eve-as-polls-betting-markets-predict-tight-white-ho">선거 전날 변동성 있는 트럼프 미디어 주식, 여론조사와 베팅 시장이 백악관 경합을 예측</a>
&#8220;힘스 앤 허스 브랜드 모두에서 개선된 모멘텀이 다시 한 번 강력한 성장과 수익성의 분기를 가져왔다&#8221;고 공동 창립자 겸 CEO인 앤드류 두덤(Andrew Dudum)이 말했다. &#8220;고객에게 편리하고 투명하며 저렴한 진료 접근성을 제공하는 전략에 대한 실행이 우리를 전국의 수백만 명에게 도달하게 하고 있다.&#8221;
전망: 힘스앤 허스는 4분기 매출을 4억 6,500만 달러에서 4억 7,000만 달러로 예상하고, 2024 회계연도 매출 가이던스를 14억 6,000만 달러에서 14억 6,500만 달러로 상향 조정했다. 이는 13억 9,600만 달러 추정치에 비해 증가한 수치이다.
HIMS 주가 변동: <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>에 따르면, 힘스 앤 허스의 주식은 월요일 애프터 마켓에서 7.56% 상승하여 22.33달러에 거래되었다.
또한 읽어볼 기사:
<ul>
<li><a href="https://www.benzinga.com/general/gaming/24/11/41719896/alibaba-layoffs-hit-metaverse-division-will-the-chinese-e-commerce-giant-double-down-on-ai">알리바바, 메타버스 부문 감원: 중국 전자상거래 거인이 AI에 다시 투자할까?</a></li>
</ul>
사진: Hims &amp; Hers Health, Inc. 제공

힘스 앤 허스 헬스(NYSE:<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/hims" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for HIMS">HIMS</a>)는 월요일 2분기 재무 결과를 발표했다. 보고서의 <a href="https://www.benzinga.com/pressreleases/24/08/b40170755/hims-hers-health-inc-reports-second-quarter-2024-financial-results">세부 정보</a>는 다음과 같다.
주요 정보: 힘스 앤 허스 헬스는 분석가 합의 추정치인 3센트를 웃도는 주당 6센트의 분기 이익을 보고했다.
분기별 매출은 3억 1,564만 8천 달러로 분석가 컨센서스 추정치를 5.24% 상회했으며, 이는 지난해 같은 기간 매출 2억 791만 2천 달러보다 51.82% 증가한 수치이다.
2023년 2분기 1,000만 달러에 비해 2024년 2분기 총이익률은 81%, 잉여 현금 흐름은 4,760만 달러였다.
"우리의 2분기 결과는 이미 놀라운 궤적이었던 것의 가속화를 나타낸다. 해당 분기 동안 우리 플랫폼의 구독자는 190만 명에 달해 전년 대비 43% 증가했다"고 공동 창립자이자 CEO인 앤드류 두둠(Andrew Dudum)이 말했다.
"우리는 삶을 변화시키는 솔루션에 대한 접근이 간단하고 편리하며 저렴해야 하며 개인을 위해 설계되어야 한다고 믿고 있다. 우리 플랫폼의 기능을 확장함에 따라 우리는 전국 모든 가정의 개인이 기분 좋게 느낄 수 있도록 도울 수 있다는 확신이 더욱 커졌다."
전망: 힘스 앤 허스는 3분기 매출이 3억 7,500만~3억 8,000만 달러, 연간 매출이 13억 7,000만~14억 달러에 이를 것으로 예상하고 있다.
HIMS Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" target="_blank" rel="noopener">Benzinga Pro</a>, Hims &amp; Hers Health shares are down 10.59% after-hours at $15.95 at the time of publication Monday.
HIMS 주가 움직임: 힘스 앤 허스의 주식은 <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>에 따르면 월요일 애프터마켓에서 큰 폭의 등락을 반복한 후 0.50% 하락한 17.75달러를 기록했다.
Image: Courtesy of Hims&amp; Hers Health, Inc.
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

다음은 지난주 큰 폭의 상승세를 보인 6개의 중형주 주식이다. 이 주식들은 여러분의 포트폴리오에 있나요?
<ol>
<li>AST 스페이스모바일(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>)의 주가는 회사가 <a class="ticker" href="https://www.benzinga.com//node/39958682">첫 5개의 상용 위성</a>을 성공적으로 완료하면서 47.88% 상승했다.</li>
<li>구스헤드 인슈어런스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSHD#NASDAQ">GSHD</a>)의 주가는 긍정적인 <a class="ticker" href="https://www.benzinga.com/stock/GSHD#NASDAQ">2분기</a> 실적에 힘입어 39.86% 상승했다.</li>
<li>비아샛(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSAT#NASDAQ">VSAT</a>)의 주가는 30.78% 상승했다. 회사는 새로운 보고 부문 구조를 <a class="ticker" href="https://www.benzinga.com//node/39973735">발표</a>했다.</li>
<li>바이킹 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VKTX#NASDAQ">VKTX</a>)의 주가는 <a href="https://www.benzinga.com//node/39966690" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">VK2735의 3단계 진출</a> 발표 이후 29.86% 상승했다.</li>
<li>빔 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAM#NASDAQ">BEAM</a>)의 주식은 HC 웨인라이트(Wainwright)가 매수 등급으로 해당 주식에 대한 커버리지를 시작하고 <a class="ticker" href="https://www.benzinga.com/quote/BEAM/analyst-ratings">80달러의 목표 주가를</a> 발표한 후 주가는 23.93% 상승했다.</li>
<li>셀덱스 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLDX#NASDAQ">CLDX</a>)의 주식은 19.72% 올랐다.</li>
</ol>
다음 읽기:
<ul>
<li><a href="https://kr.benzinga.com/news/usa/stocks/%ec%9c%a0%eb%8b%88%eb%b2%84%ec%85%9c-%ed%97%ac%ec%8a%a4-%eb%b0%8f-%eb%a1%9d%ed%9e%88%eb%93%9c-%eb%a7%88%ed%8b%b4%ec%9d%80-%ec%a7%80%eb%82%9c%ec%a3%bc-%ec%b5%9c%ea%b3%a0-%ec%84%b1%ea%b3%bc%eb%a5%bc/" target="_blank" rel="noopener">유니버셜 헬스 및 록히드 마틴은 지난주 최고 성과를 보여준 11개 대형주 중 일부 (7월 21일-7월 27일)</a></li>
<li><a href="https://kr.benzinga.com/news/usa/stocks/%ed%8f%ac%eb%93%9c-%ec%8a%a4%ed%85%94%eb%9e%80%ed%8b%b0%ec%8a%a4-%eb%b0%8f-%eb%8d%b8%ec%9d%80-%ec%a7%80%eb%82%9c%ec%a3%bc-%ec%b5%9c%ec%95%85%ec%9d%98-%ec%84%b1%ea%b3%bc%eb%a5%bc-%eb%b3%b4%ec%9d%b8-12/" target="_blank" rel="noopener">포드, 스텔란티스 및 델은 지난주 최악의 성과를 보인 12개 대형주 중 일부 (7월 21일부터 7월 27일)</a></li>
</ul>
AST SpaceMobile을 통한 사진
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

Hims & Hers Health

뉴스

에 대한 최신 뉴스 Hims & Hers Health (NYSE:HIMS) 주식

화요일, 11월 05, 2024

월요일, 11월 04, 2024

월요일, 8월 05, 2024

월요일, 7월 29, 2024

화요일, 5월 07, 2024

일요일, 5월 05, 2024

뉴스

파트너 / 기고자

벤징가 글로벌